Wednesday, February 8, 2017 12:27 AM
(NYSE: AGN) this week announced the launch of its “See America” campaign, a new U.S.-focused initiative to fight preventable blindness and to advocate for making vision health “a priority for all Americans.”
Friday, February 3, 2017 12:24 AM
BRIDGEWATER, N.J.—February is National Age-related Macular Degeneration (AMD) Awareness Month and Bausch + Lomb
along with Prevent Blindness
are partnering for a second year in a row on the #WhyEyeFight Campaign.
Monday, January 30, 2017 12:21 AM
has named Sushanta Mallick to its ophthalmics team as vice president and global development lead for clinical development, ophthalmics, according to a company announcement.
Friday, January 27, 2017 12:18 AM
BAKERSFIELD, Calif.—Last week, Advanced Center for Eyecare
(ACE) and Bakersfield City School District, in partnership with OneSight
, opened its first system of school-based vision centers in California presented by Oakley.
Wednesday, January 18, 2017 12:27 AM
BRIDGEWATER, N.J.—Bausch + Lomb
, said it has won its patent infringement lawsuit with Vitamin Health Inc.
in U.S. District Court and will receive an undisclosed sum from Vitamin Health.
Wednesday, January 18, 2017 12:18 AM
NEW YORK—The Mount Sinai Health System
earlier this week announced plans to develop the Mount Sinai/New York Eye and Ear (NYEE) Eye and Vision Research Institute, a facility that the health system said would be “the first of its kind in the New York City metropolitan region.”
Monday, January 16, 2017 12:21 AM
NEW YORK—Smart Vision Labs
has formed a partnership with Brille24
, a leading German online optical retailer.
Monday, January 16, 2017 12:18 AM
(NYSE:UNM), a leader in employee benefits, earlier this week said it is entering a new market with the launch of Unum Vision and Unum Dental, a move that was planned as a follow-up to its April 2016 acquisition of the parent company of Starmount Life Insurance Company
and Always Care Benefits, an independent vision and dental benefits provider.
Wednesday, January 11, 2017 12:23 AM
SYLMAR, Calif.—Second Sight Medical Products, Inc.
(Nasdaq:EYES) a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind patients, has filed a registration statement on Form S-1 with the Securities and Exchange Commission for a rights offering to its existing stockholders.
Wednesday, January 11, 2017 12:18 AM
MESA, Ariz.—Paragon Vision Sciences
, a leader in orthokeratology, today announced approval from the China Food and Drug Administration (CFDA) and commercial availability of its corneal reshaping/orthokeratology brand, Paragon CRT Contact Lenses in China.
Monday, January 9, 2017 12:21 AM
announced the call for applications for its 2017 Joanne Angle Investigator Award. The award is a grant provided annually to a public health research project that seeks to put an end to unnecessary vision loss.
Friday, January 6, 2017 12:24 AM
ALEXANDRIA, Va.—The Vision Council
has announced the results of a nationwide survey detailing the effects and implications of blue light—and available eyewear treatment options—as more than 165,000 attendees gather with the latest in technology at the 2017 International Consumer Electronics Show.
Wednesday, January 4, 2017 12:18 AM
Alexandria, Va.—Show organizers for Vision Expo East have announced exclusive events for ECPs including a presentation from Google agency developer Liz Austin, a dynamic VIP networking reception, and sessions focused on utilizing Google’s digital products to grow their eyecare businesses.
Monday, January 2, 2017 12:18 AM
NEW YORK—A group of medical researchers expect that more than one-half of the world’s population will have myopia or high myopia by 2050. The projection is based on a meta-analysis of data from 145 studies (dating back to 1995) and covering 2.1 million participants.
Wednesday, December 28, 2016 12:23 AM
SYLMAR, Calif. & LAUSANNE, Switzerland—Second Sight Medical Products, Inc.
(Nasdaq:EYES), a developer, manufacturer and marketer of implantable visual prosthetics for blind patients suffering from Retinitis Pigmentosa (RP), announced it has received a positive recommendation from advisors to the U.K. Government’s health care funding authority for specialized services in England. For the first time in the U.K., the publicly-funded NHS system will fund blind patients with RP to receive treatment with the Argus II Retinal Prosthesis System (Argus II) “bionic eye.”